Medigen’s MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World H...

Full "IntellAsia: Resources" article